# DISulfiram for COvid-19 (DISCO) Trial

> **NCT04485130** · PHASE2 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 11 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Disulfiram
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04485130
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-18
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Low COVID case numbers, competing COVID treatments available
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04485130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04485130, "DISulfiram for COvid-19 (DISCO) Trial". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04485130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*